Panacea Biotec Limited’s revenue in Q3FY23 fell 26% to ₹ 11,520 lakhs. Consolidated Profit After Tax came at ₹ 1,937 lakhs in Q3FY23. In this quarter’s results, the reports suggested that the firm has reported decreased revenues and the reason for the increased profitability is the income recieved from Exceptional Items.
Panacea Biotec Q3FY23; 26% Fall in Revenue
Tags: Pharmaceutical
Related Post
- TCI Express Ltd Q4FY24; 16% fall in Profits
TCI Express Limited is an express cargo logistics company with its own set up across…
-
Tata Motors Ltd Q4FY24; 219% rise in Profits
Tata Motors Group is a leading global automobile manufacturer. Part of the illustrious multi-national conglomerate,…
-
Kalyan Jewellers India Ltd Q4FY24; 96% rise in Profits
Kalyan Jewellers India Ltd. designs manufacture and sells a range of gold, studded and other…